Condition
Corneal Scars and Opacities
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (2)
Trial Status
Unknown3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06983652Recruiting
Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema
NCT04932629Early Phase 1UnknownPrimary
To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".
NCT03295292Phase 1UnknownPrimary
Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze
NCT02948023Phase 1Unknown
Stem Cells Therapy for Corneal Blindness
Showing all 4 trials